Serum C7 levels predict liver-related events in metabolic fatty liver disease, study finds

Metabolic dysfunction-associated steatotic liver illness (MASLD) is simply a large origin of liver-related morbidity and mortality worldwide. As the illness progresses, liver fibrosis and liver-related events (LREs), including hepatocellular carcinoma and different complications, go important indicators of objective risk. However, accurately assessing fibrosis severity and predicting aboriginal LREs remains challenging. Liver biopsy is invasive and costly, portion existing noninvasive biomarkers and imaging approaches person limitations.